Advancing Oral Drug Delivery: The Impact of Solid Lipid Nanoparticles on Antiplatelet Therapy
Deepa Lalwani, Sumeet Dwivedi, Pravin Kumar Sharma, G. N. Darwhekar · European journal of parenteral & pharmaceutical sciences · 2025
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
European journal of parenteral & pharmaceutical sciences · OpenAlex · article · 2025
Abstract
The application of nanoparticle technology in oral medicine has spurred substantial research endeavours to improve the solubility, permeability, and chemical stability of different pharmaceuticals. Improving the bioavailability of poorly absorbed drugs that are significantly degraded in the mouth is a major challenge in this research. The creation of solid lipid nanoparticles (SLNs) is the main topic of this review since it seems like a possible solution to these problems. We go over the stability, characterisation, and synthesis of SLNs, highlighting their potential to improve acute coronary syndrome treatment medication administration.
The review also delves into the process by which antiplatelet SLNs work to prevent myocardial infarction, providing information about how they can enhance treatment results.
Open the resolved locator · 10.37521/ejpps30107
Metadata licence: OpenAlex metadata (CC0)